Shared Instrumentation Grant Program
Page 2

The types of research instruments that can be purchased under this program are nuclear magnetic resonance systems, electron and confocal microscopes, mass spectrometers, protein and DNA sequencers, biosensors, x-ray diffractometers and cell sorters.

The minimum cost of the instruments will be $100,000 each, and the maximum amount that will be granted per application will be $600,000.

The institutions and organizations that will be eligible to submit an application under the Shared Instrumentation Grant Program are the following:

a) Public/State Controlled Institutions of Higher Education

b) Private Institutions of Higher Education

c) Hispanic-serving Institutions

d) Historically Black Colleges and Universities (HBCUs)

e) Tribally Controlled Colleges and Universities (TCCUs)

f) Alaska Native and Native Hawaiian Serving Institutions

g) Nonprofit Organizations Other Than Institutions of Higher Education

The Department of Health and Human Services, the mother agency that is funding the Shared Instrumentation Grant Program, is the nation's principal agency that is largely responsible for protecting the health of all Americans and ensuring the provision of fundamental health and human services to all people needing such services.

Shared Instrumentation Grant Program
  Back to Page 1

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---

Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program
The Centers for Disease Control and Prevention has recently established the Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program wherein it seeks to create and evaluate a surveillance system for congenital and inherited disease conditions.

---

Department of Human Health and Services: Family Planning Services Grant
OPHS has recently announced the availability of funding opportunities for the establishment and implementation of voluntary family planning service projects.

---